Loading...
01/11 03:08
Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call reveals a decline in financial performance across multiple revenue streams, with significant year-over-year drops and a net loss. Although there are some competitive wins in VMS and MSP and growth in language services, these are characterized as small to medium. The Q&A highlights competitive pressures and management's reluctance to provide specific guidance, which could increase uncertainty. The market cap suggests moderate sensitivity, leading to a prediction of a negative stock price movement in the range of -2% to -8% over the next two weeks.
Revenue $690 million, down 16% year-over-year due to lower volume and rates, partially offset by increased labor disruption revenue.
Adjusted EBITDA $64 million, down 34% year-over-year driven by lower gross margin.
Gross Margin 28.7%, down 270 basis points year-over-year due to higher housing and per diem reimbursements.
SG&A Expenses $148 million, down from $175 million year-over-year primarily due to lower employee headcount and variable compensation.
Nurse and Allied Revenue $413 million, down 20% year-over-year primarily from lower volume and rates.
Travelers Revenue $215 million, down 36% year-over-year due to lower volume.
Allied Revenue $147 million, down 13% year-over-year due to lower volume.
Physician and Leadership Solutions Revenue $174 million, down 8% year-over-year driven by lower volume across all businesses.
Locum Tenens Revenue $141 million, down 3% year-over-year due to lower volume.
Interim Leadership Revenue $24 million, down 21% year-over-year due to lower volume.
Search Revenue $9 million, down 29% year-over-year due to lower volume.
Technology and Workforce Solutions Revenue $102 million, down 9% year-over-year as growth in Language Services was offset by decreases in BMS and outsourced solutions.
Language Services Revenue $75 million, up 5% year-over-year.
VMS Revenue $19 million, down 33% year-over-year.
Net Loss $1 million, compared to net income of $17 million in the prior year.
GAAP Diluted Loss per Share $0.03, compared to net income of $0.97 in the prior year.
Operating Cash Flow $93 million, enabling a reduction of revolving credit balance by $60 million.
Capital Expenditures $10 million.
Cash and Equivalents $56 million.
Debt $1 billion, including $150 million on the revolver.
Net Leverage Ratio 3.1x to 1.
AMN Passport App: The AMN Passport app has been rolled out to locum tenens, allowing physicians to submit their shift work through the app, which is expected to speed up the submission process and improve physician satisfaction.
ShiftWise Flex: The rollout of ShiftWise Flex is set to be completed next month, enhancing the company's staffing management and optimization platform.
Labor Disruption Revenue: AMN received $39 million in revenue from two labor disruption events in Q1, with continued activity expected in Q2.
Locum Tenens Bookings: Bookings for locum tenens have significantly increased in the first four months of the year, with expectations for sequential revenue growth.
Allied Business Demand: Demand for the Allied business has grown mid-teens year-over-year, with strong execution expected to continue.
Schools Business Bookings: Bookings for the schools business are trending towards year-over-year growth driven by strength in orders and candidate submissions.
Gross Margin Improvement: Consolidated gross margin was 28.7% in Q1, slightly better than guidance, benefiting from process changes and new technology.
Cash Flow and Debt Reduction: The company generated $93 million in operating cash flow, reducing its revolving credit balance by $60 million and adding $45 million in cash.
Technology Investment: AMN continues to invest in technology, including AI tools, to improve service delivery and reduce costs.
Client Retention and New Wins: The company signed five new MSP and vendor-neutral wins last quarter, reflecting improved win rates and strong client retention.
Competitive Pressures: The company is experiencing intense competition to fill orders, with some orders priced at levels that no one is filling. There is heightened competition in language services due to industry consolidation, leading to price competition.
Regulatory Issues: The current political and regulatory environment may be impacting demand, particularly in Spanish language services, which has shown slower growth.
Supply Chain Challenges: Ongoing low demand in nurse staffing is affecting VMS revenue, indicating potential supply chain challenges in staffing.
Economic Factors: Cost consciousness among hospitals and health systems is a persistent issue, affecting the company's ability to maintain revenue levels. Demand has not recovered to pre-pandemic levels in several business segments.
Operational Risks: The company does not control all factors determining business trajectory, indicating potential operational risks in forecasting and planning.
Revenue Performance: First quarter revenue was $690 million, exceeding guidance by $10 million due to strong performance in labor disruption, Locum Tenens, and Allied businesses.
Labor Disruption Revenue: Received $39 million in revenue from two labor disruption events in Q1, with continued activity expected in Q2.
Technology Investments: Investing in technology to improve speed and fill rates, including AI tools and the rollout of AMN Passport to enhance physician engagement.
Client Wins: Signed five new MSP and vendor-neutral contracts, reflecting improved win rates and strong client retention.
ShiftWise Flex Rollout: Completion of ShiftWise Flex rollout to clients next month, enhancing staffing management and optimization.
Industry Recognition: AMN recognized for innovation with the 2025 Innovators Award from Modern Healthcare.
Q2 Revenue Guidance: Projected consolidated revenue for Q2 is between $645 million and $660 million, down 11% to 13% year-over-year.
Gross Margin Guidance: Expected gross margin for Q2 is between 28.5% and 29%.
SG&A Expenses Guidance: Projected SG&A expenses to be 23.2% to 23.7% of revenue.
Operating Margin Guidance: Expected operating margin for Q2 is between -0.7% and 0%.
Adjusted EBITDA Margin Guidance: Expected adjusted EBITDA margin for Q2 is between 7.8% and 8.3%.
Share Repurchase Program: During the first quarter, AMN Healthcare generated $93 million in operating cash flow, enabling the company to reduce its revolving credit balance by $60 million and add $45 million of cash to its balance sheet. The company plans to continue using free cash flow to reduce its debt.
The earnings call summary and Q&A indicate a stable competitive market, growing demand for contingent labor, and positive business trends, such as increased MSP revenue and international nurse staffing growth. While management avoided specific guidance, the overall sentiment is positive with expected bill rate stabilization and strategic investments in technology. Given the company's market cap and the positive outlook, a 2% to 8% stock price increase is likely over the next two weeks.
The earnings call summary indicates a mixed performance: strong Q1 revenue but weak Q2 guidance with a projected revenue decline and negative operating margins. Additionally, a net loss due to impairment charges and legislative uncertainties affecting demand are concerning. The Q&A reveals stable demand but no clear growth catalysts, with management avoiding specifics on key issues like retrogression. Despite some positive signs (e.g., new partnerships), the overall sentiment is negative, particularly given the market cap, as smaller companies tend to react more strongly to such mixed signals.
The earnings call reveals a decline in financial performance across multiple revenue streams, with significant year-over-year drops and a net loss. Although there are some competitive wins in VMS and MSP and growth in language services, these are characterized as small to medium. The Q&A highlights competitive pressures and management's reluctance to provide specific guidance, which could increase uncertainty. The market cap suggests moderate sensitivity, leading to a prediction of a negative stock price movement in the range of -2% to -8% over the next two weeks.
The earnings call reveals significant challenges: declining gross margins, revenue, and net income, coupled with increased long-term debt. The Q&A highlighted margin pressure and competitive intensity, with management avoiding clarity on key issues. Despite some growth in specific segments, the overall sentiment is negative, reflecting weak financial performance and uncertain outlook. Given the company's small market cap, these factors are likely to drive a strong negative stock price reaction over the next two weeks.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
